ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Kakala
|
17K |
6.7M |
7 |
09/05/20 |
09/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Announcement tomorrow?
|
|
Kakala
|
6 |
2.6K |
10 |
07/05/20 |
07/05/20 |
ASX - By Stock
|
6
|
2.6K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Forbes online interview
|
|
Kakala
|
22 |
9.0K |
18 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
22
|
9.0K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Forbes online interview
|
|
Kakala
|
22 |
9.0K |
2 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
22
|
9.0K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Forbes online interview
|
|
Kakala
|
22 |
9.0K |
2 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
22
|
9.0K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Forbes online interview
|
|
Kakala
|
22 |
9.0K |
5 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
22
|
9.0K
|
5
|
|
ASX - By Stock
|
MSB |
Forbes online interview
|
|
Kakala
|
22 |
9.0K |
21 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
22
|
9.0K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
The Perfect Storm
|
|
Kakala
|
8 |
2.6K |
2 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
8
|
2.6K
|
2
|
|
ASX - By Stock
|
MSB |
The Perfect Storm
|
|
Kakala
|
8 |
2.6K |
35 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
8
|
2.6K
|
35
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Kakala
|
23K |
13M |
4 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Kakala
|
23K |
13M |
2 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Inflammatory Lung Disease Outcomes For Presentation at ISCT
|
|
Kakala
|
75 |
35K |
4 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
75
|
35K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Inflammatory Lung Disease Outcomes For Presentation at ISCT
|
|
Kakala
|
75 |
35K |
1 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
75
|
35K
|
1
|
|
ASX - By Stock
|
MSB |
Gilead
|
|
Kakala
|
2 |
1.4K |
0 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
2
|
1.4K
|
0
|
|
ASX - By Stock
|
MSB |
need an announcement
|
|
Kakala
|
3 |
1.3K |
3 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
3
|
1.3K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mount Sinai leading the way in innovative stem cell therapy for Covid-19 patients
|
|
Kakala
|
28 |
13K |
0 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
28
|
13K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mount Sinai leading the way in innovative stem cell therapy for Covid-19 patients
|
|
Kakala
|
28 |
13K |
1 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
28
|
13K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mount Sinai leading the way in innovative stem cell therapy for Covid-19 patients
|
|
Kakala
|
28 |
13K |
1 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
28
|
13K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
|
|
Kakala
|
311 |
166K |
15 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
311
|
166K
|
15
|
|
ASX - By Stock
|
MSB |
I'm Confused
|
|
Kakala
|
17 |
5.9K |
0 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
17
|
5.9K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
trial time
|
|
Kakala
|
35 |
15K |
4 |
28/03/20 |
28/03/20 |
ASX - By Stock
|
35
|
15K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
trial time
|
|
Kakala
|
35 |
15K |
12 |
28/03/20 |
28/03/20 |
ASX - By Stock
|
35
|
15K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
trial time
|
|
Kakala
|
35 |
15K |
7 |
28/03/20 |
28/03/20 |
ASX - By Stock
|
35
|
15K
|
7
|
|
ASX - By Stock
|
MSB |
trial time
|
|
Kakala
|
35 |
15K |
24 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
35
|
15K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Kakala
|
5.4K |
2.7M |
1 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
5.4K
|
2.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
|
|
Kakala
|
443 |
199K |
1 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
443
|
199K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Kakala
|
23K |
13M |
11 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
23K
|
13M
|
11
|
|
Charts
|
MSB |
Re:
here's a thought
|
|
Kakala
|
16 |
8.7K |
13 |
23/12/19 |
23/12/19 |
Charts
|
16
|
8.7K
|
13
|
|
Charts
|
MSB |
Re:
here's a thought
|
|
Kakala
|
16 |
8.7K |
7 |
23/12/19 |
23/12/19 |
Charts
|
16
|
8.7K
|
7
|
|
Charts
|
MSB |
Re:
here's a thought
|
|
Kakala
|
16 |
8.7K |
1 |
23/12/19 |
23/12/19 |
Charts
|
16
|
8.7K
|
1
|
|
Charts
|
MSB |
here's a thought
|
|
Kakala
|
16 |
8.7K |
18 |
22/12/19 |
22/12/19 |
Charts
|
16
|
8.7K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Lonza Enter GVHD Commercial Manufacturing Agreement
|
|
Kakala
|
193 |
102K |
11 |
26/10/19 |
26/10/19 |
ASX - By Stock
|
193
|
102K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Revascor Orphan Drug For End Stage CHF With LVADs
|
|
Kakala
|
57 |
25K |
2 |
24/06/19 |
24/06/19 |
ASX - By Stock
|
57
|
25K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Revascor Orphan Drug For End Stage CHF With LVADs
|
|
Kakala
|
57 |
25K |
1 |
24/06/19 |
24/06/19 |
ASX - By Stock
|
57
|
25K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Initiates Rolling Submission of BLA for GvHD
|
|
Kakala
|
33 |
13K |
7 |
30/05/19 |
30/05/19 |
ASX - By Stock
|
33
|
13K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Initiates Rolling Submission of BLA for GvHD
|
|
Kakala
|
33 |
13K |
2 |
30/05/19 |
30/05/19 |
ASX - By Stock
|
33
|
13K
|
2
|
|
ASX - By Stock
|
AVQ |
Re:
Ann: Funding Update
|
|
Kakala
|
128 |
49K |
7 |
16/05/19 |
16/05/19 |
ASX - By Stock
|
128
|
49K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Kakala
|
4.4K |
2.4M |
11 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
11
|
|
ASX - By Stock
|
AVQ |
Re:
Ann: Funding Update
|
|
Kakala
|
128 |
49K |
5 |
12/05/19 |
12/05/19 |
ASX - By Stock
|
128
|
49K
|
5
|
|
ASX - By Stock
|
M4M |
Re:
So much for a billion reasons to smile
|
|
Kakala
|
64 |
27K |
0 |
10/04/19 |
10/04/19 |
ASX - By Stock
|
64
|
27K
|
0
|
|
ASX - By Stock
|
M4M |
So much for a billion reasons to smile
|
|
Kakala
|
64 |
27K |
4 |
10/04/19 |
10/04/19 |
ASX - By Stock
|
64
|
27K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Waislitz on MSB
|
|
Kakala
|
41 |
18K |
12 |
04/04/19 |
04/04/19 |
ASX - By Stock
|
41
|
18K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Licensee Files For Skin Disease Marketing Approval
|
|
Kakala
|
27 |
16K |
12 |
26/03/19 |
26/03/19 |
ASX - By Stock
|
27
|
16K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Licensee Files For Skin Disease Marketing Approval
|
|
Kakala
|
27 |
16K |
19 |
25/03/19 |
25/03/19 |
ASX - By Stock
|
27
|
16K
|
19
|
|
ASX - By Stock
|
AVQ |
is that it?
|
|
Kakala
|
230 |
149K |
2 |
01/03/19 |
01/03/19 |
ASX - By Stock
|
230
|
149K
|
2
|
|
ASX - By Stock
|
AVQ |
Re:
Ann: Trading Halt
|
|
Kakala
|
46 |
23K |
17 |
28/02/19 |
28/02/19 |
ASX - By Stock
|
46
|
23K
|
17
|
|
ASX - By Stock
|
MSB |
Capital Research closing their position on MSB - WRONG
|
|
Kakala
|
9 |
5.2K |
16 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
9
|
5.2K
|
16
|
|
ASX - By Stock
|
AVQ |
What an Absolute Joke
|
|
Kakala
|
44 |
24K |
13 |
16/01/19 |
16/01/19 |
ASX - By Stock
|
44
|
24K
|
13
|
|
ASX - By Stock
|
M4M |
Re:
price expectation
|
|
Kakala
|
3 |
2.5K |
3 |
16/01/19 |
16/01/19 |
ASX - By Stock
|
3
|
2.5K
|
3
|
|
ASX - By Stock
|
M4M |
price expectation
|
|
Kakala
|
3 |
2.5K |
1 |
16/01/19 |
16/01/19 |
ASX - By Stock
|
3
|
2.5K
|
1
|
|